Alecensa (Alectinib)
$11,415.51
150 mg 4 Cajas C/56 Cápsulas 224ct
... people are viewing this right now
Alectinib is an oral drug that blocks the activity of anaplastic lymphoma kinase and is used to treat non-small-cell lung cancer. It was developed by Chugai Pharmaceutical Co. Japan, which is part of the Hoffmann-La Roche group
Reviews
There are no reviews yet.